Progranulin is a growth factor in cellular activity that is known to play a key role in the proliferation of tumors. In the case of malignant mesothelioma, researchers are honing in on how progranulin interacts with signal pathways through a system of proteins and receptors in our cells.
Scientific discoveries on Hereditary Cancer Syndromes have evolved in recent years, with advances in understanding the genetic basis of various tumors and the biological underpinnings of inherited cancer syndromes.
Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.
Animal-Assisted interventions (AAI) are implemented in hospitals and rehabilitation centers to produce many advantages for the patients but could expose them to pathogens transmission, a process known as zoonosis.
A gene regulating the F-Box and WD Repeat Domain Containing 7 (FBXW7) protein is frequently mutated or deleted in various types of human cancer, including gynecological cancers.
Members of the Board of Directors of the Italian Heritage and Culture Committee-NY, Inc. (IHCC-NY) honored Dr. Antonio Giordano, Founder and Director of the Sbarro Health Research Organization (SHRO) on April 24, 2023, with its coveted Leonardo da Vinci award, awarded annually by the 47-year-old cultural organization.
A recent review paper published in the journal Cancers highlights the important role of the growth factor progranulin in the initiation and progression of cancer.
The Sbarro Health Research Organization (SHRO), led by Prof. Antonio Giordano, in collaboration with the Texas Scientific Italian Community (TSIC), led by Prof. Andrea Giuffrida, will present the XVII Conference of Italian Researchers in the World on Saturday April 1st from 9:30 AM to 3:00 PM at Temple University of Philadelphia.
Artificial Intelligence and NGS Integrated into the Next Generation Tissue Microarrays (TMA) Workshop
SHRO Founder Antonio Giordano contributes to a new publication on the use of liquid biopsy to assess the treatment response and find mutations that confer resistance to cancer therapies.
Many cardiovascular diseases, such as atherosclerosis, or ‘hardening of the arteries,’ correlate to mitochondrial dysfunction and endothelial impairment in the tissues of the heart and blood vessels.
An international research group including scientists from Italy, the United States, Ireland, and Israel have published a three-year analysis of the Mesothelioma (Me) drug trial, Check-Mate 743 (CM-743).
Researchers working with Sbarro Health Research Organization (SHRO) have published a paper examining the possible links between neurological involvement and respiratory damage due to COVID-19.
The National Italian American Foundation (NIAF) will celebrate its 47th Anniversary Gala at the elegant Omni Shoreham Hotel in Washington, D.C., on Saturday, October 29, 2022.
A new study investigated the expression of the primary cilium in mesothelioma, finding that primary cilia is preferentially lost in the more aggressive subtype of mesothelioma and further research may confirm its potential prognostic and diagnostic value.
The Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation will host the Medical Conference titled “Italian and American Perspectives on Cancer Care” on Saturday October 29th at 9:00 AM at the Omni Shoreham Hotel in Washington, DC.
Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors are potentially related to adverse events in patients with metastatic Non-Small-Cell-Lung Cancer (mNSCLC).
This week, Sbarro Health Research Organization (SHRO) Founder and President, Antonio Giordano, M.D., Ph.D., participates in a lecture sponsored by UC Berkeley’s Institute for European Studies.
Upper tract urothelial carcinoma (UTUC) is a rare malignancy accounting for 5-10% of all urothelial cancers. When considering metastatic upper tract urothelial carcinoma (mUTUC) existing data is still limited.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
